heart iconheart icon
Skip to content

News Releases

 
News Releases
  Date Title and Summary View
Nov 21, 2017
Nov 21, 2017
Nov 20, 2017
NEW BRUNSWICK, N.J., Nov. 20, 2017 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Citi 2017 Global Healthcare Conference on Thursday, Dec. 7, at Lotte New York Palace, NY.  Joaquin Duato, Executive Vice President, Worldwide Chairman, Pharmaceuticals will represent the Company in a session scheduled at 12:35 p.m. (Eastern Time...
Nov 20, 2017
Nov 14, 2017
Nov 3, 2017
Oct 30, 2017
Approval provides a much-needed option for patients who develop this life-threatening condition following stem cell transplant TORONTO, Oct. 30, 2017 /CNW/ - Janssen Inc. announced today that following Priority Review, Health Canada has approved IMBRUVICA® (ibrutinib), an oral, once-daily targeted therapy, for the treatment of p...
Oct 30, 2017
Oct 25, 2017
NEW BRUNSWICK, N.J., Oct. 25, 2017 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the 26th Annual Credit Suisse Health Care Conference on Wednesday, Nov. 8, at The Phoenician in Scottsdale, AZ.  Vanessa Broadhurst, President, Cardiovascular & Metabolism, Janssen Pharmaceuticals and Scott White, President, Immunology, Janssen Phar...
Oct 25, 2017
Page: FirstPrevious
2
... NextLast
= add release to Briefcase